UK Markets close in 1 hr 19 mins

Why Adaptimmune Therapeutics Stock Is Crashing Today

·2-min read
Why Adaptimmune Therapeutics Stock Is Crashing Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • ADAP

Shares of the clinical-stage cell therapy company Adaptimmune Therapeutics (NASDAQ: ADAP) were down by 9.1% as of 2:37 p.m. ET on Wednesday. Earlier today, the biotech's shares were down by an unsightly 12.5% at their low point.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting